[
  {
    "ts": null,
    "headline": "Sell Novo Nordisk And Buy Viking Therapeutics",
    "summary": "Discover top obesity drug stocks: Why LLY and VKTX outshine Novo Nordisk (NVO) for long-term gains.",
    "url": "https://finnhub.io/api/news?id=eb8c6a8ccab9704c57f8dec215e057226204d2d5938f59bec35f090944614ae3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762121705,
      "headline": "Sell Novo Nordisk And Buy Viking Therapeutics",
      "id": 137299553,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/157582285/image_157582285.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover top obesity drug stocks: Why LLY and VKTX outshine Novo Nordisk (NVO) for long-term gains.",
      "url": "https://finnhub.io/api/news?id=eb8c6a8ccab9704c57f8dec215e057226204d2d5938f59bec35f090944614ae3"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Brunch: Tesla Shareholders Set To Vote On Musk's Pay",
    "summary": "Listen below or on the go via Apple Podcasts and SpotifyThe following is an abridged transcript:Tesla (TSLA) will hold its highly-anticipated shareholder...",
    "url": "https://finnhub.io/api/news?id=4f368e74b1c30393a9390a67f57bb6e3f80ffe0e687597d8a287abf0d88f706f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762091957,
      "headline": "Wall Street Brunch: Tesla Shareholders Set To Vote On Musk's Pay",
      "id": 137296438,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2156387592/image_2156387592.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Listen below or on the go via Apple Podcasts and SpotifyThe following is an abridged transcript:Tesla (TSLA) will hold its highly-anticipated shareholder...",
      "url": "https://finnhub.io/api/news?id=4f368e74b1c30393a9390a67f57bb6e3f80ffe0e687597d8a287abf0d88f706f"
    }
  },
  {
    "ts": null,
    "headline": "Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week",
    "summary": "Markets look set to enter the fifth full week of a US government shutdown as investors parse Powell's comments, news of a trade deal between Washington and Beijing, and another mammoth week of earnings.",
    "url": "https://finnhub.io/api/news?id=a90459f9d470a052272eeacfe0a45722c71f3c3a1ec2c0c4fbb19b824e28cb8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762087573,
      "headline": "Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week",
      "id": 137294329,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Markets look set to enter the fifth full week of a US government shutdown as investors parse Powell's comments, news of a trade deal between Washington and Beijing, and another mammoth week of earnings.",
      "url": "https://finnhub.io/api/news?id=a90459f9d470a052272eeacfe0a45722c71f3c3a1ec2c0c4fbb19b824e28cb8a"
    }
  },
  {
    "ts": null,
    "headline": "Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk",
    "summary": "Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.",
    "url": "https://finnhub.io/api/news?id=28f2b8110e3b07169ad95c96e9161ccd4673fa0d3ee31319e14b017d2ea4f3cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762079400,
      "headline": "Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk",
      "id": 137294499,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.",
      "url": "https://finnhub.io/api/news?id=28f2b8110e3b07169ad95c96e9161ccd4673fa0d3ee31319e14b017d2ea4f3cb"
    }
  },
  {
    "ts": null,
    "headline": "Is It Time to Dump Your Shares of Pfizer?",
    "summary": "Pfizer stock has dropped 50% over the past three years.",
    "url": "https://finnhub.io/api/news?id=2242d59f8aba0788e1bdb5cef00ef165409ced8bddd154296811a32b31ac5f4f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762075200,
      "headline": "Is It Time to Dump Your Shares of Pfizer?",
      "id": 137294824,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer stock has dropped 50% over the past three years.",
      "url": "https://finnhub.io/api/news?id=2242d59f8aba0788e1bdb5cef00ef165409ced8bddd154296811a32b31ac5f4f"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Week Ahead",
    "summary": "Get the latest stock market updates, key earnings previews, and gold investing insights.",
    "url": "https://finnhub.io/api/news?id=8834350af1a837126d8db68e94fded0a34364f99b03586b0dad5dee085578cc3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762067228,
      "headline": "Wall Street Week Ahead",
      "id": 137292957,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1451753827/image_1451753827.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Get the latest stock market updates, key earnings previews, and gold investing insights.",
      "url": "https://finnhub.io/api/news?id=8834350af1a837126d8db68e94fded0a34364f99b03586b0dad5dee085578cc3"
    }
  }
]